Orrick Herrington & Sutcliffe LLP advised Guide Therapeutics on the deal.Guide Therapeutics (GuideTx), a developer of nonviral drug delivery vehicles for genetic medicines, announced its acquisition by…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
